Coloplast A/S (OTCMKTS:CLPBY) Shares Pass Below 50 Day Moving Average – Time to Sell?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $7.98 and traded as low as $7.00. Coloplast A/S shares last traded at $7.12, with a volume of 473,515 shares changing hands.

Analysts Set New Price Targets

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Coloplast A/S currently has a consensus rating of “Hold”.

Coloplast A/S Stock Down 2.7%

The company has a market cap of $15.02 billion, a PE ratio of 23.62, a P/E/G ratio of 0.69 and a beta of 0.33. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50. The stock has a 50-day moving average of $7.94 and a 200-day moving average of $8.66.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings results on Friday, February 6th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.01. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%.The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.12 billion. Sell-side analysts predict that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.